| |
| |
|
| Insider
Information: |
Baird William D Iii |
| Relationship: |
|
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
449,004 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,268,601 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
449,004 |
|
|
| Total
Value |
$1,268,601 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-4.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -153.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amicus Therapeutics Inc |
FOLD |
Chief Financial Officer |
2018-10-15 |
117,622 |
2014-04-10 |
0 |
Premium* |
|
|
Bluebird Bio, Inc. |
BLUE |
Chief Financial Officer |
2021-11-11 |
22,797 |
2019-03-01 |
0 |
Premium* |
|
|
2seventy Bio, Inc. |
TSVT |
|
2024-04-01 |
308,585 |
2022-01-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
59 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2015-05-11 |
4 |
AS |
$10.84 |
$268,810 |
D/D |
(24,800) |
6,575 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Chief Financial Officer |
• – – |
2020-02-13 |
4 |
S |
$90.60 |
$113,612 |
D/D |
(1,254) |
13,746 |
0 |
% |
|
| BLUE |
Bluebird Bio, Inc. |
Chief Financial Officer |
• – – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Chief Financial Officer |
• – – |
2021-02-12 |
4 |
S |
$45.52 |
$55,352 |
D/D |
(1,216) |
21,581 |
0 |
% |
|
| BLUE |
Bluebird Bio, Inc. |
Chief Financial Officer |
• – – |
2021-01-06 |
4 |
S |
$44.76 |
$42,756 |
D/D |
(949) |
22,797 |
0 |
% |
|
| BLUE |
Bluebird Bio, Inc. |
Chief Financial Officer |
• – – |
2021-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
14,768 |
22,797 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Chief Financial Officer |
• – – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
23,746 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2015-05-08 |
4 |
D |
$10.80 |
$201,150 |
D/D |
(18,625) |
31,375 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Chief Financial Officer |
• – – |
2021-02-17 |
4 |
S |
$28.16 |
$19,516 |
D/D |
(693) |
35,529 |
0 |
% |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2016-09-20 |
4 |
AS |
$8.00 |
$164,075 |
D/D |
(20,500) |
35,950 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Chief Financial Officer |
• – – |
2021-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
14,641 |
36,222 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2015-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2016-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
52,950 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2016-09-20 |
4 |
OE |
$8.00 |
$28,000 |
D/D |
3,500 |
56,450 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2015-06-19 |
4 |
AS |
$13.26 |
$202,057 |
D/D |
(15,235) |
56,575 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2015-09-21 |
4 |
AS |
$16.78 |
$255,634 |
D/D |
(15,236) |
56,575 |
0 |
- |
|
| TSVT |
2seventy Bio, Inc. |
Chief Financial Officer |
• – – |
2022-02-17 |
4 |
S |
$14.78 |
$6,311 |
D/D |
(427) |
57,578 |
0 |
- |
|
| TSVT |
2seventy Bio, Inc. |
Chief Financial Officer |
• – – |
2022-01-07 |
4 |
S |
$23.91 |
$21,421 |
D/D |
(896) |
58,005 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2015-06-19 |
4 |
OE |
$13.26 |
$202,057 |
D/D |
15,235 |
71,810 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2015-09-21 |
4 |
OE |
$16.78 |
$255,634 |
D/D |
15,236 |
71,811 |
0 |
- |
|
| TSVT |
2seventy Bio, Inc. |
Chief Financial Officer |
• – – |
2023-01-11 |
4 |
S |
$10.63 |
$11,446 |
D/D |
(1,077) |
78,797 |
0 |
- |
|
| TSVT |
2seventy Bio, Inc. |
Chief Financial Officer |
• – – |
2023-01-09 |
4 |
S |
$10.33 |
$33,298 |
D/D |
(3,222) |
79,874 |
0 |
- |
|
| TSVT |
2seventy Bio, Inc. |
Chief Financial Officer |
• – – |
2022-08-05 |
4 |
S |
$16.23 |
$67,397 |
D/D |
(4,152) |
83,096 |
0 |
- |
|
| TSVT |
2seventy Bio, Inc. |
Chief Financial Officer |
• – – |
2022-07-15 |
4 |
S |
$13.81 |
$56,344 |
D/D |
(4,080) |
87,248 |
0 |
- |
|
| TSVT |
2seventy Bio, Inc. |
Chief Financial Officer |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
33,750 |
91,328 |
0 |
- |
|
59 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
